Vascular endothelial growth factor A in eyes with uveal melanoma

Archives of Ophthalmology

Volumn 124, Issue 10, 2006, Pages 1428-1434

  Missotten, Guy S O ^a   Notting, Irene C ^a   Schlingemann, Reinier O ^b   Zijlmans, Henry J ^a   Lau, Chun ^c   Eilers, Paul H C ^a   Keunen, Jan E E ^a   Jager, Martine J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN A;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; ENUCLEATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA; TUMOR LOCALIZATION; TUMOR VOLUME; UVEA MELANOMA; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; BLOTTING, WESTERN; BRACHYTHERAPY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE ENUCLEATION; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; IN SITU HYBRIDIZATION; MALE; MELANOMA; MIDDLE AGED; UVEAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33749342662     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.10.1428     Document Type: Article

References (27)

1. Bergman L, Seregard S, Nilsson B, Ringborg U, Lundell G, Ragnarsson-Olding B. Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci. 2002;43:2579-2583.
2. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma, II: a meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 1992;110:245-250.
3. Pyrhonen S. The treatment of metastatic uveal melanoma. Eur J Cancer. 1998;34(suppl 3):S27-S30.
4. Schlingemann RO, van Hinsbergh VWM. Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br J Ophthalmol. 1997;81:501-512.
5. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25:581-611.
6. Küchle M, Nguyen NX, Naumann GO. Quantitative assessment of the blood-aqueous barrier in human eyes with malignant or benign uveal tumors. Am J Ophthalmol. 1994;117:521-528.
7. Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res. 2003;22:1-29.
8. Shinoda K, Ishida S, Kawashima S, et al. Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus. Br J Ophthalmol. 1999;83:834-837.
9. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994;145:574-584.
10. Endo M, Yahagisawa K, Tsuchida K, et al. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy. Horm Metab Res. 2001;33:317-322.
11. McLaren M, Elhadd TA, Greene SA, Belch JJ. Elevated plasma vascular endothelial cell growth factor and thrombomodulin in juvenile diabetic patients. Clin Appl Thromb Hemost. 1999;5:21-24.
12. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
13. Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 1998;105:232-237.
14. Boyd SR, Tan D, Bunce C, et al. Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window. Br J Ophthalmol. 2002;86:448-452.
15. Los M, Aarsman CJ, Terpstra L, et al. Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease. Ann Oncol. 1997;8:1015-1022.
16. Ijland SA, Jager MJ, Heijdra BM, Westphal JR, Peek R. Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines. Melanoma Res. 1999;9:445-450.
17. Hernandez C, Garcia-Arumi J, Burgos R, Segura RM, Canton A, Simo R. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Diabetes Care. 2001;24:516-521.
18. Hazelbag S, Gorter A, Kenter GG, van de Broek L, Fleuren G. Transforming growth factor-β1 induces tumor stroma and reduces tumor infiltrate in cervical cancer. Hum Pathol. 2002;33:1193-1199.
19. Boyd S. Uveal melanoma and angiogenesis. In: Jager MJ, Niederkorn JY, Ksander BR, eds. Uveal Melanoma: A Model for Exploring Fundamental Cancer Biology. London, England: Taylor & Francis; 2004.
20. Boyd SR, Tan DSW, de Souza L, et al. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth. Br J Ophthalmol. 2002;86:440-447.
21. Machein MR, Plate KH. Role of VEGF in developmental angiogenesis and in tumor angiogenesis in the brain. Cancer Treat Res. 2004;117:191-218.
22. Gasparini G. Prognostic value of VEGF in breast cancer. Oncologist. 2000;5:37-44.
23. Gruba M, Seeliger H, Kleespier A, Jaugh KW, Bruns C. Vascular endothelial growth factor in colorectal cancer. Int J Colorectal Dis. 2004;19:510-517.
24. Sheidow TG, Hooper P, Crukley C, Young J, Heathcote JG. Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis. Br J Ophthalmol. 2000;84:750-756.
25. Vinores SA, Kuchle M, Mahlow J, Chiu C, Green WR, Campochiaro PA. Blood-ocular barrier breakdown in eyes with ocular melanoma: a potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol. 1995;147:1289-1297.
26. Stitt AW, Simpson DA, Boocock C, Gardiner TA, Murphy GM, Archer DB. Expression of vascular endothelial growth factor and its receptors is regulated in eyes with intra-ocular tumors. J Pathol. 1998;186:306-312.
27. Kivela T, Eskelin S, Makitie T, Summanen P. Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance. Invest Ophthalmol Vis Sci. 2001;42:2085-2093.